Kentaro Suzuki is CMO at Nautilus Biotechnology, Inc. (NAUT). They have made 1 open-market trade across 1 company since 2025, most recently 2025-11-06.
CIK 0002037191
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NAUT | 4,000 | $8K |
Shares reported on the most recent Form 4, priced at the 2025-11-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NAUT | BUY | 2025-11-06 | 2025-11-10 | $1.49 | $6K | +23.7% | +19.3% | +26.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.